Management of ALLERGIC FUNGAL RHINOSINUSITIS (AFRS): A sever type 2 Inflammatory Disease
The management of AFRS remains challenging to reduce disease burden and limit potential structural damage complications
Learn more
HomeArticles
Latest Articles
Real-World Effectiveness of Nirsevimab: Evidence from the NIRSE-GAL Study
The NIRSE-GAL study is an ongoing population-based, prospective, longitudinal study conducted in Galicia, Spain. It includes infants eligible to receive nirsevimab and evaluates its impact on RSV-related outcomes in both inpatient and outpatient healthcare settings.
Learn more
GvHD Unpacked: A Guide to Classifications and Mechanisms
This video provides a clear overview of graft-versus-host disease, exploring its key classifications and the underlying immunological mechanisms that drive disease development and progression. It aims to support understanding of GvHD pathophysiology to inform diagnosis, management, and therapeutic decision-making.
Learn more
Expanding RSV Protection in Kuwait: New National Directives for Monoclonal Antibody Use
Summary of Kuwait’s updated RSV prevention policy
Learn more
IL-4/IL-13 Dual Cytokine Signaling in Severe Asthma: Mechanistic Insights by Prof. Kenneth Chapman
Recognizing the key cytokines driving type 2 inflammation and understanding their profound impact on patients’ asthma burden is crucial.1-3
Learn more
GOLD 2026 Report: Key Updates for COPD Management
What’s New in the GOLD 2026 Report
Learn more
Understanding PIRA in MS: An Overview with Dr. Barry Singer
Progression Independent of Relapse Activity (PIRA) represents the gradual, sustained worsening of disability that occurs even without relapses. In this video, Dr. Barry Singer explains how PIRA is defined, why it affects many patients across the MS spectrum, and how clinicians can better detect subtle changes that reflect true long-term progression.
Learn more
Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer
Kaplan–Meier curves play a key role in visualizing how clinical events—such as confirmed disability progression—evolve over time in MS studies. In this video, Dr. Barry Singer provides a clear, simplified walkthrough of how these curves are constructed, how patient data contributes to each step, and what curve separation really tells us about treatment impact. This resource offers an accessible foundation for anyone looking to better understand KM interpretation in MS research.
Learn more